In acute ischemic stroke, clinical efficacy of intravenous thrombolysis (IVT) and endovascular thrombectomy (EVT) is highly time dependent.
1-3 Endovascular thrombectomy can only be given to a subset of patients with a symptomatic large anterior vessel occlusion (sLAVO), constituting 4.9% to 14.5% of all patients with suspected stroke.
4,5 Contrary to IVT, which is available in most primary stroke centers (PSCs), EVT is an elaborate treatment and, therefore, restricted to comprehensive stroke centers (CSCs) with EVT facilities. Because sLAVO cannot be reliably identified in the ambulance, patients suspected of acute stroke are often transferred to the nearest hospital (often a PSC) to start IVT as soon as possible. For patients with sLAVO, this routing leads to a median of 60 to 109 minutes’ delay due to interhospital transfers, with associated worse functional outcomes.
6,7 Prehospital identification of patients with sLAVO enabling direct allocation to a CSC would greatly reduce delays to EVT treatment and improve clinical outcomes.